PlainRecalls
FDA Devices Moderate Class II Ongoing

Azure XT DR MRI, Model Numbers: a) W1DR01 and b) W2DR01

Reported: July 15, 2020 Initiated: June 4, 2020 #Z-2507-2020

Product Description

Azure XT DR MRI, Model Numbers: a) W1DR01 and b) W2DR01

Reason for Recall

There is a rare communication sequence during the first device interrogation with a SmartSync Device Manager that may result in the temporary suspension of some device features (i.e., battery measurements, Capture Management", Atrial Lead Position Check", EffectivCRT" algorithms, and AdaptivCRT"). This rare interaction results in temporary suspension of automatic threshold testing and output adjustments, and suspension of auto-optimization of CRT therapy. The issue is unlikely to result in clinical impact to the patient, and features are restored upon next programmer device interrogation or presence of a magnet.

Details

Units Affected
266252 devices
Distribution
worldwide
Location
Mounds View, MN

Frequently Asked Questions

What product was recalled?
Azure XT DR MRI, Model Numbers: a) W1DR01 and b) W2DR01. Recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF). Units affected: 266252 devices.
Why was this product recalled?
There is a rare communication sequence during the first device interrogation with a SmartSync Device Manager that may result in the temporary suspension of some device features (i.e., battery measurements, Capture Management", Atrial Lead Position Check", EffectivCRT" algorithms, and AdaptivCRT"). This rare interaction results in temporary suspension of automatic threshold testing and output adjustments, and suspension of auto-optimization of CRT therapy. The issue is unlikely to result in clinical impact to the patient, and features are restored upon next programmer device interrogation or presence of a magnet.
Which agency issued this recall?
This recall was issued by the FDA Devices on July 15, 2020. Severity: Moderate. Recall number: Z-2507-2020.